S-1 or Tegafur-Uracil in Treating Patients With Previously Treated Stage III or Stage IV Head and Neck Cancer
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy, such as S-1 and tegafur-uracil, work in different ways
to stop the growth of tumor cells, either by killing the cells or by stopping them from
dividing. Giving S-1 or tegafur-uracil after surgery, chemotherapy, biological therapy,
and/or radiation therapy may kill any remaining tumor cells. It is not yet known whether S-1
is more effective than tegafur-uracil in treating head and neck cancer.
PURPOSE: This randomized phase III trial is studying S-1 to see how well it works compared
with tegafur-uracil in treating patients with previously treated stage III or stage IV head
and neck cancer.